HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

decane

Networked: 67 relevant articles (1 outcomes, 4 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Acyclic Hydrocarbons
    - Alkanes: 241
      - decane: 67

Experts

1.	Obniska, Jolanta: 3 articles (11/2009 - 11/2004)
2.	Shin, Woosuck: 2 articles (05/2020 - 07/2017)
3.	Tsuruta, Akihiro: 2 articles (05/2020 - 07/2017)
4.	Cance, William G: 2 articles (01/2014 - 05/2012)
5.	Golubovskaya, Vita M: 2 articles (01/2014 - 05/2012)
6.	Aoki, Takumi: 2 articles (01/2014 - 11/2013)
7.	Fuchi, Nobuhiro: 2 articles (01/2014 - 11/2013)
8.	Higashi, Eriko: 2 articles (01/2014 - 11/2013)
9.	Kato, Yuko: 2 articles (01/2014 - 11/2013)
10.	Nakadera, Yasuhito: 2 articles (01/2014 - 11/2013)

Related Diseases

1.	Cognitive Dysfunction 11/24/1994 - "Previous reports have shown that (+/-)-YM796 (2,8-dimethyl-3-methylene-1-oxa-8-azaspiro[4.5]decane) exhibits M1 agonistic activity and ameliorates cognitive impairment, and that the (-)-S isomer is active in in vitro studies. "
2.	Chronic Obstructive Pulmonary Disease (COPD) 11/01/2021 - "Measurements and Main Results: We identified a novel VOC signature comprising decane and other long-chain alkane compounds that is induced during RV infection of cultured airway epithelial cells and is also increased in the exhaled breath from healthy subjects experimentally challenged with RV and from patients with COPD during naturally occurring viral exacerbations. " 07/01/2021 - "ethane and 3,7-dimethylnonane for asthma and α-methylstyrene and decane for COPD), these were not consistently identified across studies. "
3.	Asthma (Bronchial Asthma) 07/01/2021 - "ethane and 3,7-dimethylnonane for asthma and α-methylstyrene and decane for COPD), these were not consistently identified across studies. " 01/01/2021 - "In addition, carbon disulfide, a tetrahydroisoquinoline derivative, 2-ethyl-1-hexanol and decane discriminated asthma disease among patients with other atopic disorders. "
4.	Rheumatoid Arthritis 08/01/1997 - "One of these compounds, SK&F 106615 (N,N-diethyl-8,8-dipropyl-2-azaspiro[4.5]decane-2-propanamine++ + dihydrochloride), is now in phase II clinical trials for rheumatoid arthritis. " 07/11/2005 - "Atiprimod (2-(3-Diethylaminopropyl)-8,8-dipropyl-2-azaspiro[4,5] decane dimaleate) has exerted anti-inflammatory activities and inhibited oeteoclast-induced bone resorption in animal models and been well tolerated in patients with rheumatoid arthritis in phase I clinical trials. "
5.	Myocardial Infarction 01/01/2018 - "Discovery of Novel 1,3,8-Triazaspiro[4.5]decane Derivatives That Target the c Subunit of F1/FO-Adenosine Triphosphate (ATP) Synthase for the Treatment of Reperfusion Damage in Myocardial Infarction." 01/01/2018 - "In this manuscript, we validated a new pharmacological approach as an adjunct to reperfusion in myocardial infarction (MI) treatment and describe the discovery, optimization, and structure-activity relationship (SAR) studies of the first small-molecule mPTP opening inhibitors based on a 1,3,8-triazaspiro[4.5]decane scaffold that targets the c subunit of the F1/FO-ATP synthase complex. "

Related Drugs and Biologics

1.	azaspirane
2.	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)
3.	Ethane
4.	Adenosine Triphosphate (ATP)
5.	vinyltoluene
6.	Volatile Organic Compounds
7.	SK&F 105685
8.	Biomarkers (Surrogate Marker)
9.	Alkanes
10.	Styrene (Styrol)

Related Therapies and Procedures

1.	Electronic Nose
2.	Lasers (Laser)
3.	Drug Therapy (Chemotherapy)
4.	Canes (Cane)